Valuation : InspireMD, Inc.

Market Cap 36.26M 31.18M 29.42M 26.8M 50.1M 3.47B 50.56M 350M 135M 1.76B 136M 133M 5.58B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 36.26M 31.18M 29.42M 26.8M 50.1M 3.47B 50.56M 350M 135M 1.76B 136M 133M 5.58B EV / Sales 2026 *
3.7x
EV / Sales 2027 * 1.8x
Free-Float
80.03%
Yield 2026 *
-
Yield 2027 * -
1 day-1.28%
1 week-7.44%
Current month-12.45%
1 month-2.55%
3 months+0.58%
6 months-52.45%
Current year-56.19%
1 week 0.75
Extreme 0.7529
0.86
1 month 0.75
Extreme 0.7529
1.02
Current year 0.63
Extreme 0.63
1.98
1 year 0.63
Extreme 0.63
2.56
3 years 0.63
Extreme 0.63
3.85
5 years 0.63
Extreme 0.63
5.06
10 years 0.63
Extreme 0.63
115,237.62
Manager TitleAgeSince
Chief Executive Officer 62 2019-12-31
Director of Finance/CFO 58 2025-06-24
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2017-06-01
Director/Board Member 68 2013-02-06
Director/Board Member 62 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/27/26 Buy

Chairman

20,000 0.0427%
5/27/26
Osiris Investment Partners LLC
OtherCompany 0 0% -
5/19/26 Sell

Executive/Senior Manager

-22,778 0.0486%
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-7.44%-67.50%-77.78% 36.26M
-1.95%-12.33%-29.50%-6.75% 104B
+0.32%-3.15%-27.61%-3.47% 11.67B
-5.23%-5.53%+94.68%+129.07% 10.04B
-2.18%-2.63%-54.42%-71.10% 3.99B
-1.02%-3.28%-28.54%+34.56% 2.4B
+2.47%+9.62%-13.52%-69.66% 1.97B
-3.34%-8.14% - - 1.81B
-1.11%-1.83%-22.89%-28.32% 1.53B
Average -1.48%-3.95%-18.66%-11.68% 15.22B
Weighted average by Cap. -1.93%-10.12%-20.53%+1.28%

Financials

2026 *2027 *
Net sales 9.8M 8.43M 7.95M 7.24M 13.54M 937M 13.66M 94.7M 36.45M 475M 36.8M 35.99M 1.51B 20.13M 17.31M 16.34M 14.88M 27.82M 1.92B 28.07M 195M 74.88M 976M 75.6M 73.95M 3.1B
Net income - -
Net Debt - -
Logo InspireMD, Inc.
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Employees
127
Date Price Change Volume
26-09-10 US$0.7799 -1.28% 39,002
26-09-09 US$0.7900 -4.83% 48,641
26-09-08 US$0.8301 -2.71% 72,384
26-09-04 US$0.8532 +1.26% 30,331
26-09-03 US$0.8426 +0.28% 28,909
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.7799USD
Average target price
3.333USD
Spread / Average Target
+327.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NSPR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!